75 results on '"Campani D"'
Search Results
2. Molecular landscape of intraductal papillary mucinous neoplasms of the pancreas
Catalog
Books, media, physical & digital resources
3. Epidemiology and Pathology of Liver Metastases
4. Neuropsychological Subtypes and Rate of Progression in Alzheimer’s Disease
5. Pharmacokinetic Evaluation of Two Monoclonal Antibodies as Possible Immunoscintigraphy Agents for Pancreatic Cancer in Humans
6. Characterization of mismatch repair deficiency in biliary tract cancer
7. Everolimus vs Mycophenolate Mofetil in Combination With Tacrolimus: A Propensity Score-matched Analysis in Liver Transplantation
8. P.08.24 EUS-FNA WET-TECHNIQUE IN 31 SOLID PANCREATIC LESIONS: PISA EXPERIENCE
9. Salvage of an Octogenarian Liver Graft Using Normothermic Perfusion: A Case Report
10. Enhancer of zest homolog 2 (EZH2) expression in well and moderately differentiated pancreatic neuroendocrine tumor (pNET)
11. Enhancer of zeste homolog 2 (EZH2) expression in G1 -G2 Pancreatic Neuroendocrine Tumor (pNET)
12. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET
13. Use of Octogenarian Donors for Liver Transplantation: A Survival Analysis
14. Early Versus Late Conversion From Twice-Daily to Once-Daily Tacrolimus After Liver Transplantation.
15. Use of HBsAg Quantification to Guide HBIG Prophylaxis After Liver Transplantation.
16. NSC-631570 alkaloid mixture modulates the human equlibrative transporter nucleoside 1 and deoxycytidine kinase gene expressions in pancreatic ductal adenocarcinoma cell cultures
17. Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation
18. Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer?
19. Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography
20. Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms
21. Microvascular density (MVD) and proliferative index (PI) in pancreatic neuroendocrine tumors (PNET) tissues: Analyses by computerized analysis (CA)
22. Complete Response (CR) after Trans-Arterial Chemoembolization (TACE) Is a Favorable Prognostic Marker for T2 Hepatocellular Carcinoma (HCC) Patients Undergoing Liver Transplantation (LT)
23. Gemcitabine – Ukrain combination affects MMP9 expression in primary pancreatic adenocarcinoma cell cultures (PPCCs)
24. Sub-Micrometric Liposomes as Drug Delivery Systems in the Treatment and Periodontitis
25. Histopathologic response to FOLFOXIRI plus bevacizumab of liver metastases from colorectal cancer.
26. PMP22 genetic alteration and modulation of PMP22 expression by NSC-631570 in pancreatic ductal adenocarcinoma (PDAC).
27. Molecular mechanisms underlying the synergistic interaction of the novel anticancer drug celandine with gemcitabine in preclinical models of pancreatic cancer.
28. Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment
29. Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger
30. Evaluation of prognostic factors and of the role of adjuvant chemotherapy in patients with invasive carcinoma derived from intraductal papillary mucinous neoplasms (IPMNs) of the pancreas.
31. Total Duodenectomy with Enteric Duct Drainage: A Rescue Operation for Duodenal Complications Occurring after Pancreas Transplantation
32. 6602 Prognostic relevance of lymph node metastases and adjuvant treatment for patients with invasive intraductal papillary mucinous (IPMNs) of the pancreas
33. IGF II EXPRESSION IN BREAST CANCER (BC): RELATIONSHIP WITH EPITHELIAL PROGESTERONE RECEPTOR
34. The Impact of Everolimus on Renal Function in Maintenance Liver Transplantation
35. Liver Transplantation for Metastatic Sinonasal Undifferentiated Carcinoma: A Case Report
36. Shwachman–Diamond syndrome presenting as a chronic liver disease
37. P-98 IGF II immunohistochemistry in breast cancer (BC). Relationship with several predictive parameters in breast malignancy
38. P-97 Predictive value of insulin like growth factor II (IGF-II) mRNA expression in breast cancer (BC)
39. PRE-LIVER TRANSPLANT TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA BEYOND MILAN CRITERIA
40. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer
41. Missense mutations in theTGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes
42. Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues
43. Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves’ ophthalmopathy treated successfully with glucocorticoids themselves
44. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients
45. SPORADIC PANCREATIC DUCTAL CARCINOMA IN PATIENTS AGED LESS THAN 40 YEARS.
46. A SINGLE INSTITUTION EXPERIENCE WITH PANCREATECTOMIES ASSOCIATED TO VASCULAR RESECTION.
47. Vascular Endothelial Growth Factor (Vegf) and Other Common Tissue Prognostic Indicators in Breast Cancer: A Case-Control Study
48. HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support
49. Vascular endothelial growth factor (VEGF) and other common tissue prognostic indicators in breast cancer: A case-control study
50. Recurrence of HCV infection in liver transplant patients
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.